Nutrient Limitation Governs Metabolism and Niche Adaptation in the Human Nose

English version České info

Colonization of the human nose by Staphylococcus aureus in one-third of the population represents a major risk factor for invasive infections. The basis for adaptation of S. aureus to this specific habitat and reasons for the human predisposition to become colonized have remained largely unknown. Human nasal secretions were analyzed by metabolomics and found to contain potential nutrients in rather low amounts. No significant differences were found between S. aureus carriers and non-carriers, indicating that carriage is not associated with individual differences in nutrient supply. A synthetic nasal medium (SNM3) was composed based on the metabolomics data that permits consistent growth of S. aureus isolates. Key genes were expressed in SNM3 in a similar way as in the human nose, indicating that SNM3 represents a suitable surrogate environment for in vitro simulation studies. While the majority of S. aureus strains grew well in SNM3, most of the tested coagulase-negative staphylococci (CoNS) had major problems to multiply in SNM3 supporting the notion that CoNS are less well adapted to the nose and colonize preferentially the human skin. Global gene expression analysis revealed that, during growth in SNM3, S. aureus depends heavily on de novo synthesis of methionine. Accordingly, the methionine-biosynthesis enzyme cysteine-γ-synthase (MetI) was indispensable for growth in SNM3, and the MetI inhibitor DL-propargylglycine inhibited S. aureus growth in SNM3 but not in the presence of methionine. Of note, metI was strongly up-regulated by S. aureus in human noses, and metI mutants were strongly abrogated in their capacity to colonize the noses of cotton rats. These findings indicate that the methionine biosynthetic pathway may include promising antimicrobial targets that have previously remained unrecognized. Hence, exploring the environmental conditions facultative pathogens are exposed to during colonization can be useful for understanding niche adaptation and identifying targets for new antimicrobial strategies.

Vyšlo v časopise: Nutrient Limitation Governs Metabolism and Niche Adaptation in the Human Nose. PLoS Pathog 10(1): e32767. doi:10.1371/journal.ppat.1003862
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003862

Souhrn

Zdroje

1. LowyFD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520–532.

2. MilesAA (1941) Some problems of wound infection. The Lancet 238: 507–510.

3. KrismerB, PeschelA (2011) Does Staphylococcus aureus nasal colonization involve biofilm formation? Future Microbiol 6: 489–493.

4. WeidenmaierC, GoerkeC, WolzC (2012) Staphylococcus aureus determinants for nasal colonization. Trends Microbiol 20: 243–250.

5. OttoM (2009) Staphylococcus epidermidis–the ‘accidental’ pathogen. Nat Rev Microbiol 7: 555–567.

6. GouldJC, McKE (1954) The carriage of Staphylococcus pyogenes var. aureus in the human nose. J Hyg (Lond) 52: 304–310.

7. van BelkumA, VerkaikNJ, de VogelCP, BoelensHA, VerveerJ, et al. (2009) Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199: 1820–1826.

8. von EiffC, BeckerK, MachkaK, StammerH, PetersG (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344: 11–16.

9. WertheimHF, VosMC, OttA, van BelkumA, VossA, et al. (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364: 703–705.

10. van BelkumA, MellesDC, NouwenJ, van LeeuwenWB, van WamelW, et al. (2009) Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9: 32–47.

11. WeidenmaierC, Kokai-KunJF, KristianSA, ChanturiyaT, KalbacherH, et al. (2004) Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 10: 243–245.

12. WeidenmaierC, PeschelA (2008) Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 6: 276–287.

13. O'BrienLM, WalshEJ, MasseyRC, PeacockSJ, FosterTJ (2002) Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol 4: 759–770.

14. WertheimHF, WalshE, ChoudhurryR, MellesDC, BoelensHA, et al. (2008) Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med 5: e17.

15. ClarkeSR, AndreG, WalshEJ, DufreneYF, FosterTJ, et al. (2009) Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect Immun 77: 2408–2416.

16. MulcahyME, GeogheganJA, MonkIR, O'KeeffeKM, WalshEJ, et al. (2012) Nasal Colonisation by Staphylococcus aureus Depends upon Clumping Factor B Binding to the Squamous Epithelial Cell Envelope Protein Loricrin. PLoS Pathog 8: e1003092.

17. BurianM, WolzC, GoerkeC (2010) Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans. PLoS One 5: e10040.

18. BurianM, RautenbergM, KohlerT, FritzM, KrismerB, et al. (2010) Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J Infect Dis 201: 1414–1421.

19. ClarkeSR, WiltshireMD, FosterSJ (2004) IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. Mol Microbiol 51: 1509–1519.

20. PynnonenM, StephensonRE, SchwartzK, HernandezM, BolesBR (2011) Hemoglobin promotes Staphylococcus aureus nasal colonization. PLoS Pathog 7: e1002104.

21. BrownSA, PalmerKL, WhiteleyM (2008) Revisiting the host as a growth medium. Nat Rev Microbiol 6: 657–666.

22. BodeLG, KluytmansJA, WertheimHF, BogaersD, Vandenbroucke-GraulsCM, et al. (2010) Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362: 9–17.

23. PatelJB, GorwitzRJ, JerniganJA (2009) Mupirocin resistance. Clin Infect Dis 49: 935–941.

24. VanthanouvongV, RoomansGM (2004) Methods for determining the composition of nasal fluid by X-ray microanalysis. Microsc Res Tech 63: 122–128.

25. LorinMI, GaerlanPF, MandelID (1972) Quantitative composition of nasal secretions in normal subjects. J Lab Clin Med 80: 275–281.

26. MahRA, FungDY, MorseSA (1967) Nutritional requirements of Staphylococcus aureus S-6. Appl Microbiol 15: 866–870.

27. BiswasL, BiswasR, NerzC, OhlsenK, SchlagM, et al. (2009) Role of the twin-arginine translocation pathway in Staphylococcus. J Bacteriol 191: 5921–5929.

28. NouwenJL, OttA, Kluytmans-VandenberghMF, BoelensHA, HofmanA, et al. (2004) Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a “culture rule”. Clin Infect Dis 39: 806–811.

29. AasJA, PasterBJ, StokesLN, OlsenI, DewhirstFE (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43: 5721–5732.

30. O'HaraAM, ShanahanF (2006) The gut flora as a forgotten organ. EMBO Rep 7: 688–693.

31. FrankDN, FeazelLM, BessesenMT, PriceCS, JanoffEN, et al. (2010) The human nasal microbiota and Staphylococcus aureus carriage. PLoS One 5: e10598.

32. TatusovRL, KooninEV, LipmanDJ (1997) A genomic perspective on protein families. Science 278: 631–637.

33. KiserKB, Cantey-KiserJM, LeeJC (1999) Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect Immun 67: 5001–5006.

34. CheungJ, BeasleyFC, LiuS, LajoieGA, HeinrichsDE (2009) Molecular characterization of staphyloferrin B biosynthesis in Staphylococcus aureus. Mol Microbiol 74: 594–608.

35. XiongA, SinghVK, CabreraG, JayaswalRK (2000) Molecular characterization of the ferric-uptake regulator, fur, from Staphylococcus aureus. Microbiology 146 (Pt 3) 659–668.

36. JohnstonM, JankowskiD, MarcotteP, TanakaH, EsakiN, et al. (1979) Suicide inactivation of bacterial cystathionine gamma-synthase and methionine gamma-lyase during processing of L-propargylglycine. Biochemistry 18: 4690–4701.

37. Kokai-KunJF (2008) The Cotton Rat as a Model for Staphylococcus aureus nasal colonization in humans: cotton rat S. aureus nasal colonization model. Methods Mol Biol 431: 241–254.

38. NassetES, HealdFP, CallowayDH, MargenS, SchneemanP (1979) Amino acids in human blood plasma after single meals of meat, oil, sucrose and whiskey. J Nutr 109: 621–630.

39. GoerkeC, WolzC (2010) Adaptation of Staphylococcus aureus to the cystic fibrosis lung. Int J Med Microbiol 300: 520–525.

40. GossCH, MuhlebachMS (2011) Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros 10: 298–306.

41. PalmerKL, AyeLM, WhiteleyM (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 8079–8087.

42. PetersenLJ (1999) Interstitial lactate levels in human skin at rest and during an oral glucose load: a microdialysis study. Clin Physiol 19: 246–250.

43. FerreiraMT, MansoAS, GasparP, PinhoMG, NevesAR (2013) Effect of oxygen on glucose metabolism: utilization of lactate in Staphylococcus aureus as revealed by in vivo NMR studies. PLoS One 8: e58277.

44. MillerRD, FungDY (1973) Amino acid requirements for the production of enterotoxin B by Staphylococcus aureus S-6 in a chemically defined medium. Appl Microbiol 25: 800–806.

45. OnoueY, MoriM (1997) Amino acid requirements for the growth and enterotoxin production by Staphylococcus aureus in chemically defined media. Int J Food Microbiol 36: 77–82.

46. StringfellowWT, DassyB, LiebM, FournierJM (1991) Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media. Appl Environ Microbiol 57: 618–621.

47. TaylorD, HollandKT (1989) Amino acid requirements for the growth and production of some exocellular products of Staphylococcus aureus. J Appl Bacteriol 66: 319–329.

48. MalachowaN, WhitneyAR, KobayashiSD, SturdevantDE, KennedyAD, et al. (2011) Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 6: e18617.

49. den ReijerPM, Lemmens-den ToomN, KantS, SnijdersSV, BoelensH, et al. (2013) Characterization of the Humoral Immune Response during Staphylococcus aureus Bacteremia and Global Gene Expression by Staphylococcus aureus in Human Blood. PLoS One 8: e53391.

50. Wos-OxleyML, PlumeierI, von EiffC, TaudienS, PlatzerM, et al. (2010) A poke into the diversity and associations within human anterior nare microbial communities. ISME J 4: 839–851.

51. DewhirstFE, ChenT, IzardJ, PasterBJ, TannerAC, et al. (2010) The human oral microbiome. J Bacteriol 192: 5002–5017.

52. ChoSH, StricklandI, BoguniewiczM, LeungDY (2001) Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 108: 269–274.

53. WiderstromM, WistromJ, SjostedtA, MonsenT (2012) Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis 31: 7–20.

54. HuL, UmedaA, AmakoK (1995) Typing of Staphylococcus epidermidis colonizing in human nares by pulsed-field gel electrophoresis. Microbiol Immunol 39: 315–319.

55. BastosMC, CeottoH, CoelhoML, NascimentoJS (2009) Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Curr Pharm Biotechnol 10: 38–61.

56. BierbaumG, SahlHG (2009) Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10: 2–18.

57. WankeI, SteffenH, ChristC, KrismerB, GotzF, et al. (2011) Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 131: 382–390.

58. ColeAM, DewanP, GanzT (1999) Innate antimicrobial activity of nasal secretions. Infect Immun 67: 3267–3275.

59. IwaseT, UeharaY, ShinjiH, TajimaA, SeoH, et al. (2010) Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465: 346–349.

60. BirkenstockT, LiebekeM, WinstelV, KrismerB, GekelerC, et al. (2012) Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens. J Biol Chem 287: 2887–2895.

61. MajerczykCD, DunmanPM, LuongTT, LeeCY, SadykovMR, et al. (2010) Direct targets of CodY in Staphylococcus aureus. J Bacteriol 192: 2861–2877.

62. PohlK, FrancoisP, StenzL, SchlinkF, GeigerT, et al. (2009) CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J Bacteriol 191: 2953–2963.

63. SchoenfelderSM, MarincolaG, GeigerT, GoerkeC, WolzC, et al. (2013) Methionine Biosynthesis in Staphylococcus aureus Is Tightly Controlled by a Hierarchical Network Involving an Initiator tRNA-Specific T-box Riboswitch. PLoS Pathog 9: e1003606.

64. GeigerT, FrancoisP, LiebekeM, FraunholzM, GoerkeC, et al. (2012) The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog 8: e1003016.

65. PalmerKL, MashburnLM, SinghPK, WhiteleyM (2005) Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187: 5267–5277.

66. VogguL, SchlagS, BiswasR, RosensteinR, RauschC, et al. (2006) Microevolution of cytochrome bd oxidase in Staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol 188: 8079–8086.

67. MarcotteP, WalshC (1975) Active site-directed inactivation of cystathionine gamma-synthetase and glutamic pyruvic transaminase by propargylglycine. Biochem Biophys Res Commun 62: 677–682.

68. RaoAM, DrakeMR, StipanukMH (1990) Role of the transsulfuration pathway and of gamma-cystathionase activity in the formation of cysteine and sulfate from methionine in rat hepatocytes. J Nutr 120: 837–845.

69. SteegbornC, ClausenT, SondermannP, JacobU, WorbsM, et al. (1999) Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration. J Biol Chem 274: 12675–12684.

70. PaulBD, SnyderSH (2012) H(2)S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 13: 499–507.

71. KazakovaSV, HagemanJC, MatavaM, SrinivasanA, PhelanL, et al. (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352: 468–475.

72. DuthieES, LorenzLL (1952) Staphylococcal coagulase; mode of action and antigenicity. Journal of General Microbiology 6: 95–107.

73. MackD, SiemssenN, LaufsR (1992) Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect Immun 60: 2048–2057.

74. GhebremedhinB, LayerF, KonigW, KonigB (2008) Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J Clin Microbiol 46: 1019–1025.

75. LiebekeM, DorriesK, ZuhlkeD, BernhardtJ, FuchsS, et al. (2011) A metabolomics and proteomics study of the adaptation of Staphylococcus aureus to glucose starvation. Mol Biosyst 7: 1241–1253.

76. BhagwatAA, PhadkeRP, WheelerD, KalantreS, GudipatiM, et al. (2003) Computational methods and evaluation of RNA stabilization reagents for genome-wide expression studies. J Microbiol Methods 55: 399–409.

77. PfafflMW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.

78. EdgarR, DomrachevM, LashAE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207–210.

79. MonkIR, ShahIM, XuM, TanMW, FosterTJ (2012) Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. MBio 3.